PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and various other services. The company’s major products include cytogenetic reagents, ELISA Kits, tissue biomarker reagents, atomic spectroscopy instruments, chromatography instruments, molecular spectroscopy, newborn screening instruments, and thermal analysis instruments. It offers reagents, instruments, assay platforms and software to hospitals, clinicians, medical labs and medical research professionals. PerkinElmer also offers cord blood and tissue banking, laboratory and research services. Its products are used in atomic spectroscopy, cell imaging and analysis, chromatography, analysis and detection, DNA/RNA isolation, in vivo imaging, molecular spectroscopy, protein analysis and detection, and tissue imaging, among others. The company operates in Asia, Europe and Americas. PerkinElmer is headquartered in Waltham, Massachusetts, the US. PerkinElmer is headquartered in Waltham, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company PerkinElmer Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- PerkinElmer Inc Company Overview
- PerkinElmer Inc Company Snapshot
- PerkinElmer Inc Pipeline Products and Ongoing Clinical Trials Overview
- PerkinElmer Inc - Pipeline Analysis Overview
- Business Description
- PerkinElmer Inc - Key Facts
- PerkinElmer Inc - Major Products and Services
- PerkinElmer Inc Pipeline Products by Development Stage
- PerkinElmer Inc Ongoing Clinical Trials by Trial Status
- PerkinElmer Inc Pipeline Products Overview
- Accentis - Allergy
- Accentis - Allergy Product Overview
- Accentis - Autoimmune Disorders
- Accentis - Autoimmune Disorders Product Overview
- Accentis - Endocrine Disorders
- Accentis - Endocrine Disorders Product Overview
- Accentis - Infectious Diseases
- Accentis - Infectious Diseases Product Overview
- Anti-SARS-CoV-2 Elisa (IgA)
- Anti-SARS-CoV-2 Elisa (IgA) Product Overview
- Anti-SARS-CoV-2 Elisa (IgA) Clinical Trial
- Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Assay
- Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Assay Product Overview
- B Cell ELISPOT Assay
- B Cell ELISPOT Assay Product Overview
- Dexela Flat Panel X-ray Detector 2321
- Dexela Flat Panel X-ray Detector 2321 Product Overview
- Diagnostic Assay - Oncology
- Diagnostic Assay - Oncology Product Overview
- Diagnostic Kit - Candida Krusei
- Diagnostic Kit - Candida Krusei Product Overview
- Diagnostic Kit - Candida Tropicalis
- Diagnostic Kit - Candida Tropicalis Product Overview
- Diagnostic Kit - Rubella Virus
- Diagnostic Kit - Rubella Virus Product Overview
- Diagnostic Kit - Yersinia Enterocolitica
- Diagnostic Kit - Yersinia Enterocolitica Product Overview
- Diagnostic Test - Autoimmune And Inflammatory Disease
- Diagnostic Test - Autoimmune And Inflammatory Disease Product Overview
- Diagnostic Test - Chagas Disease
- Diagnostic Test - Chagas Disease Product Overview
- Diagnostic Test - Chronic Infections
- Diagnostic Test - Chronic Infections Product Overview
- Diagnostic Test - HIV
- Diagnostic Test - HIV Product Overview
- Diagnostic Test - Homocysteine
- Diagnostic Test - Homocysteine Product Overview
- Diagnostic Test - Preterm Birth
- Diagnostic Test - Preterm Birth Product Overview
- Dry Blood Spot Test - COVID 19
- Dry Blood Spot Test - COVID 19 Product Overview
- Evoya
- Evoya Product Overview
- GENLISA Human Anti SARS-CoV-2 Nucleocapsid Protein IgG ELISA
- GENLISA Human Anti SARS-CoV-2 Nucleocapsid Protein IgG ELISA Product Overview
- GENLISA Human Anti SARS-CoV-2 Spike Protein IgG ELISA
- GENLISA Human Anti SARS-CoV-2 Spike Protein IgG ELISA Product Overview
- GENLISA Human SARS-CoV-2 Spike Protein Antigen ELISA
- GENLISA Human SARS-CoV-2 Spike Protein Antigen ELISA Product Overview
- Human DcCoV Antigen ELISA
- Human DcCoV Antigen ELISA Product Overview
- Human HCoV-229E Antigen ELISA
- Human HCoV-229E Antigen ELISA Product Overview
- Human HCoV-HKU1 Antigen ELISA
- Human HCoV-HKU1 Antigen ELISA Product Overview
- Human HCoV-NL63 Antigen ELISA
- Human HCoV-NL63 Antigen ELISA Product Overview
- Human HCoV-OC43 Antigen ELISA
- Human HCoV-OC43 Antigen ELISA Product Overview
- Human MERS-CoV Antigen ELISA
- Human MERS-CoV Antigen ELISA Product Overview
- Human SARS-CoV Antigen ELISA
- Human SARS-CoV Antigen ELISA Product Overview
- IDS-i10 - Infectious Disease Assay
- IDS-i10 - Infectious Disease Assay Product Overview
- IDS-i10 - Allergy Assay
- IDS-i10 - Allergy Assay Product Overview
- IDS-iSYS - 17-beta Estradiol Assay
- IDS-iSYS - 17-beta Estradiol Assay Product Overview
- IDS-iSYS - Androstenedione Assay
- IDS-iSYS - Androstenedione Assay Product Overview
- IDS-iSYS - DHEA-S
- IDS-iSYS - DHEA-S Product Overview
- IDS-iSYS Bioactive PTH (1-84) Kit
- IDS-iSYS Bioactive PTH (1-84) Kit Product Overview
- IgE Allergy Test - DP 3134-1601-1 E
- IgE Allergy Test - DP 3134-1601-1 E Product Overview
- IgE Allergy Test - DP 3134-1601-2 E
- IgE Allergy Test - DP 3134-1601-2 E Product Overview
- Immune Response Test
- Immune Response Test Product Overview
- Lyme C6/C10 Rapid Test
- Lyme C6/C10 Rapid Test Product Overview
- Optical Scatter Imaging System - Cancer
- Optical Scatter Imaging System - Cancer Product Overview
- PerkinElmer Five-Plex qPCR Assay
- PerkinElmer Five-Plex qPCR Assay Product Overview
- PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Saliva
- PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Saliva Product Overview
- RA Analyzer 10
- RA Analyzer 10 Product Overview
- Rapid Test - COVID-19
- Rapid Test - COVID-19 Product Overview
- Rapid Test Kit - MethylGlyoxal
- Rapid Test Kit - MethylGlyoxal Product Overview
- Risk Stratification System - Kidney Transplantation
- Risk Stratification System - Kidney Transplantation Product Overview
- SARS Diagnostic Test
- SARS Diagnostic Test Product Overview
- SARS-CoV-2 Interferon-gamma Release Assay
- SARS-CoV-2 Interferon-gamma Release Assay Product Overview
- Stratokine
- Stratokine Product Overview
- T-SPOT.COVID Test
- T-SPOT.COVID Test Product Overview
- T-SPOT.COVID Test Clinical Trial
- T-SPOT.ICA Assay
- T-SPOT.ICA Assay Product Overview
- UREA And T-SPOT Based Diagnostic Assay - Immunological Disease
- UREA And T-SPOT Based Diagnostic Assay - Immunological Disease Product Overview
- UREA And T-SPOT Based Diagnostic Assay - Infectious Disease
- UREA And T-SPOT Based Diagnostic Assay - Infectious Disease Product Overview
- ViaCyte
- ViaCyte Product Overview
- PerkinElmer Inc - Key Competitors
- PerkinElmer Inc - Key Employees
- PerkinElmer Inc - Key Employee Biographies
- PerkinElmer Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Recent Developments
- PerkinElmer Inc, Recent Developments
- Mar 09, 2023: PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
- Feb 24, 2023: PerkinElmer launches EnVison Nexus multimode plate reader to drive improved research and discovery workflows
- Nov 21, 2022: PerkinElmer helps accelerate gene therapy research with industry-first ready-to-use viral vector assays
- Nov 08, 2022: PerkinElmer Announces Financial Results for the Third Quarter of 2022
- Aug 01, 2022: PerkinElmer Announces Financial Results for the Second Quarter of 2022
- Jun 21, 2022: PerkinElmer introduces next generation, automated gas chromatography platform
- Jun 16, 2022: PerkinElmer and Novartis Collaborate to Address the Unmet Need of Sickle Cell Disease in Sub-Saharan Africa
- Jun 06, 2022: PerkinElmer launches BioQule NGS System to automate library preparation
- May 16, 2022: PerkinElmer expands genomic testing services with Ultrarapid Whole Genome Sequencing
- May 03, 2022: PerkinElmer Announces Financial Results for the First Quarter of 2022
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- PerkinElmer Inc Pipeline Products and Ongoing Clinical Trials Overview
- PerkinElmer Inc Pipeline Products by Equipment Type
- PerkinElmer Inc Pipeline Products by Indication
- PerkinElmer Inc Ongoing Clinical Trials by Trial Status
- PerkinElmer Inc, Key Facts
- PerkinElmer Inc, Major Products and Services
- PerkinElmer Inc Number of Pipeline Products by Development Stage
- PerkinElmer Inc Pipeline Products Summary by Development Stage
- PerkinElmer Inc Ongoing Clinical Trials by Trial Status
- PerkinElmer Inc Ongoing Clinical Trials Summary
- Accentis - Allergy - Product Status
- Accentis - Allergy - Product Description
- Accentis - Autoimmune Disorders - Product Status
- Accentis - Autoimmune Disorders - Product Description
- Accentis - Endocrine Disorders - Product Status
- Accentis - Endocrine Disorders - Product Description
- Accentis - Infectious Diseases - Product Status
- Accentis - Infectious Diseases - Product Description
- Anti-SARS-CoV-2 Elisa (IgA) - Product Status
- Anti-SARS-CoV-2 Elisa (IgA) - Product Description
- Anti-SARS-CoV-2 Elisa (IgA) - Protocol for the Collection of Clinical Samples for Evaluation and Implementation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen
- Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Assay - Product Status
- Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Assay - Product Description
- B Cell ELISPOT Assay - Product Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific Inc
- Spectris Plc
- Bio-Rad Laboratories Inc
- Beckman Coulter Inc
- Harvard Bioscience Inc
- MilliporeSigma
- Precipio Inc
- Shimadzu Corp
